Thinking outside the box: Using metastasis suppressors as molecular tools

Seminars in Cancer Biology

Volumn 21, Issue 2, 2011, Pages 89-98

  Thiolloy, Sophie ^a   Rinker Schaeffer, Carrie W ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cancer progression; Cell signaling; Metastasis; Metastasis suppressors

Indexed keywords

BETA CATENIN; CASPASE 8; CD82 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; DELETED IN LIVER CANCER 1 PROTEIN; ELONGATION FACTOR 1; ELONGATION FACTOR 1A1; ENDOTHELIN 1; GELSOLIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HORMONALLY UPREGULATED NEU ASSOCIATED KINASE; HYDROLASE INHIBITOR; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 17; METASTIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; NERVE CELL ADHESION MOLECULE; NUCLEOSIDE DIPHOSPHATE KINASE NM23; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN CDC42; PROTEIN SERINE THREONINE KINASE; RAC1 PROTEIN; RHO GUANOSINE DIPHOSPHATE DISSOCIATED INHIBITOR 2; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SRC SUPPRESSED C KINASE SUBSTRATE; UNCLASSIFIED DRUG; UVOMORULIN;

BREAST CANCER; BREAST CANCER METASTASIS SUPPRESSOR 1 GENE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOGENICITY; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; DISEASE FREE SURVIVAL; FOCAL ADHESION; GENE; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS INHIBITION; METASTASIS SUPPRESSOR GENE; NONHUMAN; OVARY CANCER; PHENOTYPIC VARIATION; PROGNOSIS; PROSTATE CANCER; REVIEW; UPREGULATION;

ANIMALS; CELL ADHESION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR BIOLOGY; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 79952069716     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2010.12.008     Document Type: Review

References (116)

1. Weiss L. Metastatic inefficiency. Adv Cancer Res 1990, 54:159-211.
2. Steeg P.S., Bevilacqua G., Kopper L., Thorgeirsson U.P., Talmadge J.E., Liotta L.A., et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988, 80:200-204.
3. Dong J.T., Lamb P.W., Rinker-Schaeffer C.W., Vukanovic J., Ichikawa T., Isaacs J.T., et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995, 268:884-886.
4. Rinker-Schaeffer C.W., O'Keefe J.P., Welch D.R., Theodorescu D. Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application. Clin Cancer Res 2006, 12:3882-3889.
5. Boissan M., Dabernat S., Peuchant E., Schlattner U., Lascu I., Lacombe M.L. The mammalian Nm23/NDPK family: from metastasis control to cilia movement. Mol Cell Biochem 2009, 329:51-62.
6. Kantor J.D., McCormick B., Steeg P.S., Zetter B.R. Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res 1993, 53:1971-1973.
7. Jung S., Paek Y.W., Moon K.S., Wee S.C., Ryu H.H., Jeong Y.I., et al. Expression of Nm23 in gliomas and its effect on migration and invasion in vitro. Anticancer Res 2006, 26:249-258.
8. Lee H.Y., Lee H. Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity. Cancer Lett 1999, 145:93-99.
9. Suzuki E., Ota T., Tsukuda K., Okita A., Matsuoka K., Murakami M., et al. nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation. Int J Cancer 2004, 108:207-211.
10. Hsu S., Huang F., Ossowski L., Friedman E. Colon carcinoma cells with inactive nm23 show increased motility and response to motility factors. Carcinogenesis 1995, 16:2259-2262.
11. Russell R.L., Pedersen A.N., Kantor J., Geisinger K., Long R., Zbieranski N., et al. Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines. Br J Cancer 1998, 78:710-717.
12. Khan M.H., Yasuda M., Higashino F., Haque S., Kohgo T., Nakamura M., et al. nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Am J Pathol 2001, 158:1785-1791.
13. Kim S.H., Kim J. Reduction of invasion in human fibrosarcoma cells by ribosomal protein S3 in conjunction with Nm23-H1 and ERK. Biochim Biophys Acta 2006, 1763:823-832.
14. Horak C.E., Lee J.H., Elkahloun A.G., Boissan M., Dumont S., Maga T.K., et al. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. Cancer Res 2007, 67:7238-7246.
15. Horak C.E., Mendoza A., Vega-Valle E., Albaugh M., Graff-Cherry C., McDermott W.G., et al. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2. Cancer Res 2007, 67:11751-11759.
16. Murakami M., Meneses P.I., Knight J.S., Lan K., Kaul R., Verma S.C., et al. Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1. Int J Cancer 2008, 123:500-510.
17. Sun H.Q., Yamamoto M., Mejillano M., Yin H.L. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem 1999, 274:33179-33182.
18. Wang E., Yin H.L., Krueger J.G., Caliguiri L.A., Tamm I. Unphosphorylated gelsolin is localized in regions of cell-substratum contact or attachment in Rous sarcoma virus-transformed rat cells. J Cell Biol 1984, 98:761-771.
19. Cunningham C.C., Stossel T.P., Kwiatkowski D.J. Enhanced motility in NIH 3T3 fibroblasts that overexpress gelsolin. Science 1991, 251:1233-1236.
20. Azuma T., Witke W., Stossel T.P., Hartwig J.H., Kwiatkowski D.J. Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J 1998, 17:1362-1370.
21. De Corte V., Bruyneel E., Boucherie C., Mareel M., Vandekerckhove J., Gettemans J. Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. EMBO J 2002, 21:6781-6790.
22. Shieh D.B., Godleski J., Herndon J.E., Azuma T., Mercer H., Sugarbaker D.J., et al. Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gelsolin expression. Cancer 1999, 85:47-57.
23. Thor A.D., Edgerton S.M., Liu S., Moore D.H., Kwiatkowski D.J. Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers. Clin Cancer Res 2001, 7:2415-2424.
24. Gdynia G., Grund K., Eckert A., Bock B.C., Funke B., Macher-Goeppinger S., et al. Basal caspase activity promotes migration and invasiveness in glioblastoma cells. Mol Cancer Res 2007, 5:1232-1240.
25. Uchida K., Masumori N., Takahashi A., Itoh N., Kato K., Matusik R.J., et al. Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP. Prostate 2006, 66:536-545.
26. Ke H., Parron V.I., Reece J., Zhang J.Y., Akiyama S.K., French J.E. BCL2 inhibits cell adhesion, spreading, and motility by enhancing actin polymerization. Cell Res 2010, 20:458-469.
27. Rao J. Targeting actin remodeling profiles for the detection and management of urothelial cancers - a perspective for bladder cancer research. Front Biosci 2002, 7:e1-e8.
28. DerMardirossian C., Bokoch G.M. GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol 2005, 15:356-363.
29. Golovanov A.P., Chuang T.H., DerMardirossian C., Barsukov I., Hawkins D., Badii R., et al. Structure-activity relationships in flexible protein domains: regulation of rho GTPases by RhoGDI and D4 GDI. J Mol Biol 2001, 305:121-135.
30. Scheffzek K., Stephan I., Jensen O.N., Illenberger D., Gierschik P. The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI. Nat Struct Biol 2000, 7:122-126.
31. Oxford G., Theodorescu D. The role of Ras superfamily proteins in bladder cancer progression. J Urol 2003, 170:1987-1993.
32. Gildea J.J., Seraj M.J., Oxford G., Harding M.A., Hampton G.M., Moskaluk C.A., et al. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 2002, 62:6418-6423.
33. Hu L.D., Zou H.F., Zhan S.X., Cao K.M. Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis. Oncol Rep 2007, 17:1383-1389.
34. Theodorescu D., Sapinoso L.M., Conaway M.R., Oxford G., Hampton G.M., Frierson H.F., et al. Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 2004, 10:3800-3806.
35. Titus B., Frierson H.F., Conaway M., Ching K., Guise T., Chirgwin J., et al. Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. Cancer Res 2005, 65:7320-7327.
36. Hernandez-Perera O., Perez-Sala D., Soria E., Lamas S. Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells. Circ Res 2000, 87:616-622.
37. Masaki T. Historical review: endothelin. Trends Pharmacol Sci 2004, 25:219-224.
38. Moissoglu K., McRoberts K.S., Meier J.A., Theodorescu D., Schwartz M.A. Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases. Cancer Res 2009, 69:2838-2844.
39. Dransart E., Olofsson B., Cherfils J. RhoGDIs revisited: novel roles in Rho regulation. Traffic 2005, 6:957-966.
40. Hordijk P.L., ten Klooster J.P., van der Kammen R.A., Michiels F., Oomen L.C., Collard J.G. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 1997, 278:1464-1466.
41. Uhlenbrock K., Eberth A., Herbrand U., Daryab N., Stege P., Meier F., et al. The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism. J Cell Sci 2004, 117:4863-4871.
42. Buchsbaum R.J. Rho activation at a glance. J Cell Sci 2007, 120:1149-1152.
43. Goodison S., Yuan J., Sloan D., Kim R., Li C., Popescu N.C., et al. The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res 2005, 65:6042-6053.
44. Yuan B.Z., Jefferson A.M., Millecchia L., Popescu N.C., Reynolds S.H. Morphological changes and nuclear translocation of DLC1 tumor suppressor protein precede apoptosis in human non-small cell lung carcinoma cells. Exp Cell Res 2007, 313:3868-3880.
45. Shih Y.P., Liao Y.C., Lin Y., Lo S.H. DLC1 negatively regulates angiogenesis in a paracrine fashion. Cancer Res 2010.
46. Kim T.Y., Lee J.W., Kim H.P., Jong H.S., Jung M., Bang Y.J. DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma. Biochem Biophys Res Commun 2007, 355:72-77.
47. Jin Y., Tian X., Shang Y., Huang P. Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line. Oncol Rep 2008, 19:669-674.
48. Raftopoulou M., Hall A. Cell migration: Rho GTPases lead the way. Dev Biol 2004, 265:23-32.
49. Healy K.D., Hodgson L., Kim T.Y., Shutes A., Maddileti S., Juliano R.L., et al. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms. Mol Carcinog 2008, 47:326-337.
50. Zhou X., Zimonjic D.B., Park S.W., Yang X.Y., Durkin M.E., Popescu N.C. DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis. Int J Oncol 2008, 32:1285-1291.
51. Kim T.Y., Kim I.S., Jong H.S., Lee J.W., Jung M., Bang Y.J. Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells. Exp Mol Med 2008, 40:639-646.
52. Kawai K., Iwamae Y., Yamaga M., Kiyota M., Ishii H., Hirata H., et al. Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology. Genes Cells 2009, 14:227-241.
53. Kawai K., Kitamura S.Y., Maehira K., Seike J., Yagisawa H. START-GAP1/DLC1 is localized in focal adhesions through interaction with the PTB domain of tensin2. Adv Enzyme Regul 2010, 50:202-215.
54. Zhong D., Zhang J., Yang S., Soh U.J., Buschdorf J.P., Zhou Y.T., et al. The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration. J Cell Sci 2009, 122:414-424.
55. Gelman I.H. The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development. Front Biosci 2002, 7:d1782-d1797.
56. Lin X., Tombler E., Nelson P.J., Ross M., Gelman I.H. A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J Biol Chem 1996, 271:28430-28438.
57. Xia W., Unger P., Miller L., Nelson J., Gelman I.H. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res 2001, 61:5644-5651.
58. Su B., Bu Y., Engelberg D., Gelman I.H. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway. J Biol Chem 2010, 285:4578-4586.
59. Meng W., Takeichi M. Adherens junction: molecular architecture and regulation. Cold Spring Harb Perspect Biol 2009, 1:a002899.
60. Schmalhofer O., Brabletz S., Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009, 28:151-166.
61. Kashima T., Nakamura K., Kawaguchi J., Takanashi M., Ishida T., Aburatani H., et al. Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int J Cancer 2003, 104:147-154.
62. Hsu M.Y., Wheelock M.J., Johnson K.R., Herlyn M. Shifts in cadherin profiles between human normal melanocytes and melanomas. J Investig Dermatol Symp Proc 1996, 1:188-194.
63. Suyama K., Shapiro I., Guttman M., Hazan R.B. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2002, 2:301-314.
64. Feltes C.M., Kudo A., Blaschuk O., Byers S.W. An alternatively spliced cadherin-11 enhances human breast cancer cell invasion. Cancer Res 2002, 62:6688-6697.
65. Qi J., Chen N., Wang J., Siu C.H. Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. Mol Biol Cell 2005, 16:4386-4397.
66. Qi J., Wang J., Romanyuk O., Siu C.H. Involvement of Src family kinases in N-cadherin phosphorylation and beta-catenin dissociation during transendothelial migration of melanoma cells. Mol Biol Cell 2006, 17:1261-1272.
67. Fu Z., Smith P.C., Zhang L., Rubin M.A., Dunn R.L., Yao Z., et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 2003, 95:878-889.
68. Hagan S., Al-Mulla F., Mallon E., Oien K., Ferrier R., Gusterson B., et al. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 2005, 11:7392-7397.
69. Li H.Z., Wang Y., Gao Y., Shao J., Zhao X.L., Deng W.M., et al. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 2008, 6:917-928.
70. Miska E.A. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005, 15:563-568.
71. Zlobec I., Baker K., Minoo P., Jass J.R., Terracciano L., Lugli A. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin Cancer Res 2008, 14:143-148.
72. Schuierer M.M., Bataille F., Hagan S., Kolch W., Bosserhoff A.K. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 2004, 64:5186-5192.
73. Chen Y., Ouyang G.L., Yi H., Li M.Y., Zhang P.F., Li C., et al. Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis. J Proteome Res 2008, 7:5254-5262.
74. Li H.Z., Gao Y., Zhao X.L., Liu Y.X., Sun B.C., Yang J., et al. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res 2009, 7:832-840.
75. Baritaki S., Chapman A., Yeung K., Spandidos D.A., Palladino M., Bonavida B. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction. Oncogene 2009, 28:3573-3585.
76. Beshir A.B., Ren G., Magpusao A.N., Barone L.M., Yeung K.C., Fenteany G. Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Lett 2010.
77. Miyoshi A., Kitajima Y., Sumi K., Sato K., Hagiwara A., Koga Y., et al. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer 2004, 90:1265-1273.
78. Dangi-Garimella S., Yun J., Eves E.M., Newman M., Erkeland S.J., Hammond S.M., et al. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J 2009, 28:347-358.
79. Gumireddy K., Li A., Gimotty P.A., Klein-Szanto A.J., Showe L.C., Katsaros D., et al. KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat Cell Biol 2009, 11:1297-1304.
80. Li Y., Yang J., Luo J.H., Dedhar S., Liu Y. Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor Id1. J Am Soc Nephrol 2007, 18:449-460.
81. Lyden D., Young A.Z., Zagzag D., Yan W., Gerald W., O'Reilly R., et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999, 401:670-677.
82. Gupta G.P., Minn A.J., Kang Y., Siegel P.M., Serganova I., Cordon-Cardo C., et al. Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol 2005, 70:149-158.
83. Swarbrick A., Roy E., Allen T., Bishop J.M. Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response. Proc Natl Acad Sci U S A 2008, 105:5402-5407.
84. Quintela-Fandino M., Arpaia E., Brenner D., Goh T., Yeung F.A., Blaser H., et al. HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1. Proc Natl Acad Sci U S A 2010, 107:2622-2627.
85. Gardner H.P., Wertheim G.B., Ha S.I., Copeland N.G., Gilbert D.J., Jenkins N.A., et al. Cloning and characterization of Hunk, a novel mammalian SNF1-related protein kinase. Genomics 2000, 63:46-59.
86. Barnhart B.C., Alappat E.C., Peter M.E. The CD95 type I/type II model. Semin Immunol 2003, 15:185-193.
87. Wang S., El-Deiry W.S. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 2003, 22:8628-8633.
88. Stupack D.G., Teitz T., Potter M.D., Mikolon D., Houghton P.J., Kidd V.J., et al. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 2006, 439:95-99.
89. Stupack D.G., Puente X.S., Boutsaboualoy S., Storgard C.M., Cheresh D.A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 2001, 155:459-470.
90. Zhao H., Ross F.P., Teitelbaum S.L. Unoccupied alpha(v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal. Mol Endocrinol 2005, 19:771-780.
91. Fukudome K., Furuse M., Imai T., Nishimura M., Takagi S., Hinuma Y., et al. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells. J Virol 1992, 66:1394-1401.
92. Tonoli H., Barrett J.C. CD82 metastasis suppressor gene: a potential target for new therapeutics?. Trends Mol Med 2005, 11:563-570.
93. Bandyopadhyay S., Zhan R., Chaudhuri A., Watabe M., Pai S.K., Hirota S., et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med 2006, 12:933-938.
94. Shevde L.A., Samant R.S., Goldberg S.F., Sikaneta T., Alessandrini A., Donahue H.J., et al. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp Cell Res 2002, 273:229-239.
95. Seraj M.J., Harding M.A., Gildea J.J., Welch D.R., Theodorescu D. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin Exp Metastasis 2000, 18:519-525.
96. Samant R.S., Debies M.T., Hurst D.R., Moore B.P., Shevde L.A., Welch D.R. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). Cancer Lett 2006, 235:260-265.
97. Samant R.S., Debies M.T., Shevde L.A., Verderame M.F., Welch D.R. Identification and characterization of the murine ortholog (brms1) of breast-cancer metastasis suppressor 1 (BRMS1). Int J Cancer 2002, 97:15-20.
98. Phadke P.A., Vaidya K.S., Nash K.T., Hurst D.R., Welch D.R. BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. Am J Pathol 2008, 172:809-817.
99. Zhang S., Lin Q.D., Di W. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Int J Gynecol Cancer 2006, 16:522-531.
100. Smith P.W., Liu Y., Siefert S.A., Moskaluk C.A., Petroni G.R., Jones D.R. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer. Cancer Lett 2009, 276:196-203.
101. Hurst D.R., Xie Y., Vaidya K.S., Mehta A., Moore B.P., Accavitti-Loper M.A., et al. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. J Biol Chem 2008, 283:7438-7444.
102. Meehan W.J., Samant R.S., Hopper J.E., Carrozza M.J., Shevde L.A., Workman J.L., et al. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J Biol Chem 2004, 279:1562-1569.
103. Hurst DR, Welch DR. (2010) Metastasis suppressor genes: At the interface between the environment and tumor cell growth. International Review of Cell and Molecular Biology in press.
104. Welch D.R., Chen P., Miele M.E., McGary C.T., Bower J.M., Stanbridge E.J., et al. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 1994, 9:255-262.
105. Lee J.H., Welch D.R. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 1997, 57:2384-2387.
106. Beck B.H., Welch D.R. The KISS1 metastasis suppressor: a good night kiss for disseminated cancer cells. Eur J Cancer 2010, 46:1283-1289.
107. Kotani M., Detheux M., Vandenbogaerde A., Communi D., Vanderwinden J.M., Le Poul E., et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 2001, 276:34631-34636.
108. Ohtaki T., Shintani Y., Honda S., Matsumoto H., Hori A., Kanehashi K., et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001, 411:613-617.
109. Muir A.I., Chamberlain L., Elshourbagy N.A., Michalovich D., Moore D.J., Calamari A., et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 2001, 276:28969-28975.
110. Nash K.T., Phadke P.A., Navenot J.M., Hurst D.R., Accavitti-Loper M.A., Sztul E., et al. Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. J Natl Cancer Inst 2007, 99:309-321.
111. Nash K.T., Welch D.R. The KISS1 metastasis suppressor: mechanistic insights and clinical utility. Front Biosci 2006, 11:647-659.
112. Yoshida B.A., Dubauskas Z., Chekmareva M.A., Christiano T.R., Stadler W.M., Rinker-Schaeffer C.W. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res 1999, 59:5483-5487.
113. Taylor J.L., Szmulewitz R.Z., Lotan T., Hickson J., Griend D.V., Yamada S.D., et al. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells. Cancer Lett 2008, 272:12-22.
114. Vander Griend D.J., Kocherginsky M., Hickson J.A., Stadler W.M., Lin A., Rinker-Schaeffer C.W. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res 2005, 65:10984-10991.
115. Hickson J.A., Huo D., Vander Griend D.J., Lin A., Rinker-Schaeffer C.W., Yamada S.D. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res 2006, 66:2264-2270.
116. Lotan T., Hickson J., Souris J., Huo D., Taylor J., Li T., et al. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Cancer Res 2008, 68:2166-2175.